We expressed BioID2-SLC3A2 in four RAS-dependent MM lines and enumerated changes in protein interactions by SILAC MS two days after induction of either a control shRNA or shRNAs targeting KRAS or NRAS, corresponding to the mutant isoform of RAS expressed in each MM cell line. Here, SLC3A2 is linked to Miyoshi myopathy.